Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
Arylamine N-acetyltransferases (NAT; EC 2.3.1.5) catalyse the transfer of acetyl groups from acetylCoA to xenobiotics, including drugs and carcinogens. The enzyme is found extensively in both eukaryotes and prokaryotes, yet the endogenous roles of NATs are still unclear. In order to study the proper...
Hlavní autoři: | Kawamura, A, Graham, J, Mushtaq, A, Tsiftsoglou, SA, Vath, G, Hanna, P, Wagner, C, Sim, E |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2005
|
Podobné jednotky
-
Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
Autor: Kawamura, A, a další
Vydáno: (2004) -
Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
Autor: Wang, H, a další
Vydáno: (2005) -
Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Autor: Westwood, I, a další
Vydáno: (2011) -
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
Autor: Laurieri, N, a další
Vydáno: (2014) -
Structure and mechanism of arylamine N-acetyltransferases.
Autor: Westwood, I, a další
Vydáno: (2006)